Growth Metrics

Quest Diagnostics (DGX) Share-based Compensation (2016 - 2026)

Quest Diagnostics' Share-based Compensation history spans 18 years, with the latest figure at $20.0 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 9.09% to $20.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $86.0 million, a 2.27% decrease, with the full-year FY2025 number at $88.0 million, changed 0.0% from a year prior.
  • Share-based Compensation hit $20.0 million in Q1 2026 for Quest Diagnostics, down from $25.0 million in the prior quarter.
  • Over the last five years, Share-based Compensation for DGX hit a ceiling of $27.0 million in Q4 2024 and a floor of $16.0 million in Q2 2023.
  • Historically, Share-based Compensation has averaged $20.6 million across 5 years, with a median of $20.0 million in 2024.
  • Biggest five-year swings in Share-based Compensation: dropped 15.79% in 2023 and later soared 42.11% in 2024.
  • Tracing DGX's Share-based Compensation over 5 years: stood at $22.0 million in 2022, then dropped by 13.64% to $19.0 million in 2023, then soared by 42.11% to $27.0 million in 2024, then dropped by 7.41% to $25.0 million in 2025, then decreased by 20.0% to $20.0 million in 2026.
  • Business Quant data shows Share-based Compensation for DGX at $20.0 million in Q1 2026, $25.0 million in Q4 2025, and $20.0 million in Q3 2025.